DE69413019T2 - Stickstoff enthaltende kondensierte heterocylen - Google Patents

Stickstoff enthaltende kondensierte heterocylen

Info

Publication number
DE69413019T2
DE69413019T2 DE69413019T DE69413019T DE69413019T2 DE 69413019 T2 DE69413019 T2 DE 69413019T2 DE 69413019 T DE69413019 T DE 69413019T DE 69413019 T DE69413019 T DE 69413019T DE 69413019 T2 DE69413019 T2 DE 69413019T2
Authority
DE
Germany
Prior art keywords
pct
formula
image
group represented
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69413019T
Other languages
English (en)
Other versions
DE69413019D1 (de
Inventor
Yasutaka Takase
Nobuhisa Watanabe
Hideyuki Adachi
Kohtarou Kodama
Hiroki Ishihara
Takao Saeki
Shigeru Souda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE69413019D1 publication Critical patent/DE69413019D1/de
Publication of DE69413019T2 publication Critical patent/DE69413019T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69413019T 1993-03-31 1994-03-18 Stickstoff enthaltende kondensierte heterocylen Expired - Lifetime DE69413019T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9513193 1993-03-31
PCT/JP1994/000446 WO1994022855A1 (en) 1993-03-31 1994-03-18 Nitrogen-containing fused-heterocycle compounds

Publications (2)

Publication Number Publication Date
DE69413019D1 DE69413019D1 (de) 1998-10-08
DE69413019T2 true DE69413019T2 (de) 1999-06-02

Family

ID=14129274

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413019T Expired - Lifetime DE69413019T2 (de) 1993-03-31 1994-03-18 Stickstoff enthaltende kondensierte heterocylen

Country Status (10)

Country Link
US (1) US5707998A (de)
EP (1) EP0691967B1 (de)
AT (1) ATE170519T1 (de)
AU (1) AU6264194A (de)
DE (1) DE69413019T2 (de)
DK (1) DK0691967T3 (de)
ES (1) ES2124397T3 (de)
HU (1) HUT73783A (de)
PH (1) PH31122A (de)
WO (1) WO1994022855A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
TW381092B (en) * 1995-07-07 2000-02-01 Otsuka Pharma Co Ltd Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
ATE226936T1 (de) * 1995-08-08 2002-11-15 Ono Pharmaceutical Co Hydroxamsäurederivate verwendbar zur hemmung von gelatinase
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
ZA9810766B (en) 1997-11-28 1999-05-25 Mochida Pharm Co Ltd Novel compounds having cgmp-pde inhibitory activity
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
CN1972688B (zh) * 2004-05-06 2012-06-27 沃尼尔·朗伯有限责任公司 4-苯胺基-喹唑啉-6-基-酰胺类化合物
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US8673929B2 (en) 2006-07-20 2014-03-18 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
AR076024A1 (es) 2009-04-03 2011-05-11 Schering Corp Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
EP3180006A1 (de) * 2014-08-14 2017-06-21 Bayer Pharma Aktiengesellschaft Substituierte chinolin-4-carboxamide und ihre verwendung
UA123090C2 (uk) 2015-03-04 2021-02-17 Гіліад Сайєнсіз, Інк. 4,6-ДІАМІНОПІРИДО[3,2-d]ПІРИМІДИНОВІ СПОЛУКИ, ЯКІ МОДУЛЮЮТЬ TOLL-ПОДІБНІ РЕЦЕПТОРИ
EP3507276B1 (de) 2016-09-02 2021-11-03 Gilead Sciences, Inc. Toll-like-rezeptor-modulator-verbindungen
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
CN114269432B (zh) * 2019-05-31 2024-05-07 奇斯药制品公司 作为p2x3抑制剂的氨基喹唑啉衍生物
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647540B2 (ja) * 1985-07-16 1994-06-22 エーザイ株式会社 虚血性心疾患・不整脈治療・予防剤
US5260461A (en) * 1988-01-11 1993-11-09 Massachusetts Institute Of Technology Ligands for ADH: cinchona alkaloids and moderately sized organic substituents linked through a planar aromatic spacer group
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
US5034393A (en) * 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
JP2550456B2 (ja) * 1990-11-06 1996-11-06 山之内製薬株式会社 縮合ピラジン誘導体
EP0510235A1 (de) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Benzoxazin- oder Benzothiazinderivate und Verfahren zu deren Herstellung
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
GB9314893D0 (en) * 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives

Also Published As

Publication number Publication date
WO1994022855A1 (en) 1994-10-13
AU6264194A (en) 1994-10-24
US5707998A (en) 1998-01-13
DK0691967T3 (da) 1999-06-07
ES2124397T3 (es) 1999-02-01
ATE170519T1 (de) 1998-09-15
PH31122A (en) 1998-02-23
HU9501939D0 (en) 1995-09-28
HUT73783A (en) 1996-09-30
EP0691967A1 (de) 1996-01-17
EP0691967B1 (de) 1998-09-02
DE69413019D1 (de) 1998-10-08

Similar Documents

Publication Publication Date Title
DE69413019D1 (de) Stickstoff enthaltende kondensierte heterocylen
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
MX9401408A (es) Nuevos derivados heterociclicos.
ES2159558T3 (es) Derivados de guanidina como inhibidores del intercambio na+/h+ en las celulas.
BR9206161A (pt) Derivados fluoroalcoxibenzilamino de heterociclos contendo nitrogénio
TWI262915B (en) Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
DE69419917D1 (de) Indazolderivate
CA2307581A1 (en) Heterocyclic compounds having nos inhibiting action
GB9313330D0 (en) New compound and its preparation
DE69414106T2 (de) Herbizide verbindungen
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
EP1020459A4 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
BG106117A (en) Novel 8a- and 9a-15-membered lactams
CA2211681A1 (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
DE69726437D1 (de) Benzothiophenderivate, ihre herstellung und verwendung als urokinase-inhibitoren
MX9802192A (es) Derivados novedosos del acido piridona carboxilico o sus sales, y agentes antibacterianos que contienen los mismos como sus componentes efectivos.
IL126548A0 (en) Use of aspirochlorine or derivatives thereof as immunosuppressive agents
TH76288A (th) โพรดรักของพิเพอร์แอซีน และสารต้านไวรัสซับสทิทิวเทดพิเพอริดีน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EISAI R&D MANAGEMENT CO., LTD., TOKYO, JP